Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma

NCT04731610 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT04731610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Recruiting
Start date
December 28, 2021
Completion date
December 28, 2032
Enrollment
314 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

thymoma malignant recurrent